These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 22339442
1. Target blood pressure attainment with antihypertensive therapy in Swiss primary care. Schäfer HH, Sudano I, Theus GR, Noll G, Burnier M. Blood Press; 2012 Aug; 21(4):211-9. PubMed ID: 22339442 [Abstract] [Full Text] [Related]
2. Antihypertensive medication use and blood pressure control: a community-based cross-sectional survey (ON-BP). McInnis NH, Fodor G, Moy Lum-Kwong M, Leenen FH. Am J Hypertens; 2008 Nov; 21(11):1210-5. PubMed ID: 18772857 [Abstract] [Full Text] [Related]
3. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA. J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [Abstract] [Full Text] [Related]
4. Current status of antihypertensive prescription and associated blood pressure control in Japan. Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, Umemura S. Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149 [Abstract] [Full Text] [Related]
5. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004. Gu Q, Burt VL, Paulose-Ram R, Dillon CF. Am J Hypertens; 2008 Jul; 21(7):789-98. PubMed ID: 18451806 [Abstract] [Full Text] [Related]
6. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study. Cortez-Dias N, Martins S, Belo A, Fiuza M, Investigadores do Estudo VALSIM. Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569 [Abstract] [Full Text] [Related]
7. Ambulatory hypertensive patients treated by cardiologists in France. Blacher J, Peroz-Froz J, Huberman JP, Ferrini M, Jullien G, Guenoun M, Guedj-Meynier D. Arch Cardiovasc Dis; 2013 Feb; 106(2):86-92. PubMed ID: 23527912 [Abstract] [Full Text] [Related]
8. Blood pressure target attainment in the background of guidelines: the very elderly in Swiss primary care. Schäfer HH, Sudano I, Theus GR, Zilla P, Noll G, Burnier M. Fam Pract; 2012 Oct; 29(5):511-20. PubMed ID: 22379186 [Abstract] [Full Text] [Related]
10. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice. Filippi A, Paolini I, Innocenti F, Mazzaglia G, Battaggia A, Brignoli O. J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492 [Abstract] [Full Text] [Related]
11. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial. Sato A, Watanabe S, Okubo S, Toi T, Doi T, Nakano H, Tada J, Aonuma K, I-HAT investigators. Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115 [Abstract] [Full Text] [Related]
12. [Arterial hypertension management in patients with type 2 diabetes]. Charpentier G, Genès N, Vaur L, Clerson P, Amar J, Guéret P, Cambou JP. Arch Mal Coeur Vaiss; 2002 Dec; 95(7-8):661-5. PubMed ID: 12365076 [Abstract] [Full Text] [Related]
13. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients. Neutel JM. Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863 [Abstract] [Full Text] [Related]
14. Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries. Ferrari P, National Coordinators for the Reasons for not Intensifying Antihypertensive Treatment (RIAT) trial12. J Hum Hypertens; 2009 Mar; 23(3):151-9. PubMed ID: 18784735 [Abstract] [Full Text] [Related]
15. General practitioners' approach to hypertension in urban Pakistan: disturbing trends in practice. Jafar TH, Jessani S, Jafary FH, Ishaq M, Orakzai R, Orakzai S, Levey AS, Chaturvedi N. Circulation; 2005 Mar 15; 111(10):1278-83. PubMed ID: 15769769 [Abstract] [Full Text] [Related]
16. Swiss Hypertension and Risk Factor Program (SHARP): cardiovascular risk factors management in patients with type 2 diabetes in Switzerland. Pechère-Bertschi A, Greminger P, Hess L, Philippe J, Ferrari P. Blood Press; 2005 Mar 15; 14(6):337-44. PubMed ID: 16403687 [Abstract] [Full Text] [Related]
17. Lack of control of high blood pressure and treatment recommendations in Canada. Khan N, Chockalingam A, Campbell NR. Can J Cardiol; 2002 Jun 15; 18(6):657-61. PubMed ID: 12107423 [Abstract] [Full Text] [Related]
18. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management. Petrella R, Michailidis P. Clin Ther; 2011 Sep 15; 33(9):1190-203. PubMed ID: 21885126 [Abstract] [Full Text] [Related]
19. Patients with non-insulin depending diabetes mellitus and metabolic syndrome are suboptimal treated in Swiss primary care. Schäfer HH, de Villiers JD, Lotze U, Sivukhina E, Burnier M, Noll G, Theus GR, Dieterle T. Clin Exp Hypertens; 2013 Sep 15; 35(7):496-505. PubMed ID: 23301512 [Abstract] [Full Text] [Related]
20. Amlodipine/valsartan single-pill combination: a prospective, observational evaluation of the real-life safety and effectiveness in the routine treatment of hypertension. Karpov Y, Dongre N, Vigdorchik A, Sastravaha K. Adv Ther; 2012 Feb 15; 29(2):134-47. PubMed ID: 22271158 [Abstract] [Full Text] [Related] Page: [Next] [New Search]